Citations

Citations to this article as recorded by  

• Life’s crucial 9, plasma proteomics, and the risk of major complications and mortality in MASLD
  Bing-Yun Zhang, Yi-Xin Wang, Hong-Xuan Huang, Xu-Lian Tang, Shu-Min Lai, Zhi-Yuan Xiong, Ling Kuang, Hao-Jie Chen, Hui Zhu, Ya-Xuan Li, Si-Qi Chen, Er-La Huang, Yan-Song Li, Hai-Ying Wang, Junguo Zhang, Zhi-Hao Li
  npj Metabolic Health and Disease.2026;[Epub]     CrossRef
• Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease
  Yue Wang, Sherlot Juan Song, Yichong Jiang, Jimmy Che-To Lai, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip
  Clinical and Molecular Hepatology.2025; 31(Suppl): S51.     CrossRef
• Is type 2 diabetes a link between lung function and metabolic dysfunction–associated steatotic liver disease? Insights from population studies and Mendelian randomization
  Runmin Cao, Yurun Zhang, Ling Cao, Honghe Jiang
  European Journal of Gastroenterology & Hepatology.2025; 37(5): 652.     CrossRef
• In-silico identification and experimental validation of shared genes and pathways to decipher the molecular links between COPD and MASLD
  Anupama Dubey, Praveen Kumar, Tahseen Khan, Suneel Kateriya, Dinesh Mani Tripathi, Umesh C.S. Yadav
  Computers in Biology and Medicine.2025; 194: 110532.     CrossRef
• Increased risk of acute exacerbation in obstructive airway disease: the impact of metabolic dysfunction-associated steatotic liver disease and small airway dysfunction
  Che-Hao Tseng, Bor-Yang Jou, Hsiao-Chin Shen, Hsiao-Yun Yeh, Shiao-Ya Hong, Yi-Hsuan Lin, Hung-Cheng Tsai, Tzu-Hao Li, Chien-Wei Su, Kun-Ta Chou, Diahn Warng Perng, Ying-Ying Yang, Ming-Chih Hou
  BMJ Open Respiratory Research.2025; 12(1): e003352.     CrossRef
• Association of hepatic steatosis and liver fibrosis with chronic obstructive pulmonary disease among adults
  Dayang Zheng, Xiang Liu, Wei Zeng, Wangyan Zhou, Chunxiang Zhou
  Scientific Reports.2024;[Epub]     CrossRef